Comparison between Astec LifeSciences IPO and Cox & Kings IPO.
Astec LifeSciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Cox & Kings IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Astec LifeSciences IPO is up to ₹61.50 Cr whereas the issue size of the Cox & Kings IPO is up to ₹610.39 Cr. The final issue price of Astec LifeSciences IPO is ₹82.00 per share and of Cox & Kings IPO is ₹330.00 per share.
| Astec LifeSciences IPO | Cox & Kings IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹77.00 per share | ₹316.00 per share |
| Issue Price (Upper) | ₹82.00 per share | ₹330.00 per share |
| Issue Price (Final) | ₹82.00 per share | ₹330.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 75 shares | 20 shares |
| Fresh Issue Size | 75,00,150 shares | 1,54,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹61.50 Cr | up to ₹509.85 Cr |
| OFS Issue Size | 0 shares | 30,46,640 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹100.54 Cr |
| Issue Size Total | 75,00,150 shares | 1,84,96,640 shares |
| Issue Size Total (Amount) | up to ₹61.50 Cr | up to ₹610.39 Cr |
Astec LifeSciences IPO opens on Oct 29, 2009, while Cox & Kings IPO opens on Nov 18, 2009. The closing date of Astec LifeSciences IPO and Cox & Kings IPO is Nov 04, 2009, and Nov 20, 2009, respectively.
| Astec LifeSciences IPO | Cox & Kings IPO | |
|---|---|---|
| Anchor Bid Date | Nov 17, 2009 | |
| Issue Open | Oct 29, 2009 | Nov 18, 2009 |
| Issue Close | Nov 04, 2009 | Nov 20, 2009 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Nov 25, 2009 | Dec 11, 2009 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Astec LifeSciences IPO P/E ratio is , as compared to Cox & Kings IPO P/E ratio of .
| Astec LifeSciences IPO | Cox & Kings IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 0.9999 | 84.3 | ||||
| Promoter Shareholding (Post-Issue) | 55.69 | 63.6 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹138.82 Cr. | ₹2076.46 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 35.15 | 27.53 |
In the Astec LifeSciences IPO Retail Individual Investors (RII) are offered 25,90,000 shares while in Cox & Kings IPO retail investors are offered 25,90,000 shares. Qualified Institutional Buyers (QIB) are offered 37,00,000 shares in Astec LifeSciences IPO and 64,03,840 shares in Cox & Kings IPO.
| Astec LifeSciences IPO | Cox & Kings IPO | |
|---|---|---|
| Anchor Investor Reservation | 27,44,480 shares | |
| Market Maker Reservation | ||
| QIB | 37,00,000 shares | 64,03,840 shares |
| NII | 11,10,000 shares | 27,44,496 shares |
| RII | 25,90,000 shares | 64,03,824 shares |
| Employee | 1,00,000 shares | 2,00,000 shares |
| Others | ||
| Total | 75,00,000 shares | 1,84,96,640 shares |
Astec LifeSciences IPO subscribed 1.56x in total, whereas Cox & Kings IPO subscribed 5.37x.
| Astec LifeSciences IPO | Cox & Kings IPO | |
|---|---|---|
| QIB (times) | 0.61x | 9.95x |
| NII (times) | 3.00x | 10.70x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.36x | 0.98x |
| Employee (times) | 0.50x | 0.11x |
| Other (times) | ||
| Total (times) | 1.56x | 5.37x |
